An observational study in Vestibular Schwannoma, sponsored by Shengjing Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Shengjing Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Neuroma, Acoustic with a site in China — 7 open to participants now, 7 under way, 1 of them phase 3. Neuroma, Acoustic · China.
Among the 10 studies in Neuroma, Acoustic with a site in China, this one is one of 5 that started in 2026, is one of 2 observational ones, and was the 10th registered.
101 studies on the registry are indexed under Neuroma, Acoustic; 29 are open to participants now.
Browse Neuroma, Acoustic studies →7 of the 10 studies in Neuroma, Acoustic with a site in China are open now. Recruiting first, the newest first:
Xuanwu Hospital, Beijing · Sites in China
Ages 18–65
Beijing Tiantan Hospital · Sites in China
Ages 18–70
Shengjing Hospital · Sites in China
Ages 18–75
Beijing Tiantan Hospital · Sites in China
Ages 3+
Beijing Tiantan Hospital · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 23 Neuroma, Acoustic studies recruiting now, 9 (39%) set no upper age limit and 9 (39%) stop at 75 or younger; 3 take children under 18; 4 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 1
First in 2014; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 51 across 27 observational studies indexed under Neuroma, Acoustic.
Median enrollment 95 across the 8 interventional studies, 35 across the 2 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 5 most frequent:
Shengjing Hospital is the lead sponsor of 129 studies on the registry; 61 are open to participants now.
Shengjing Hospital has 2 studies filed under Neuroma, Acoustic — fewer than ten, so there is no comparison to draw.
3 of the studies in Neuroma, Acoustic with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07844460Shengjing Hospital3D MRE-Based Evaluation of Vestibular Schwannoma Mechanical Properties and Histological Features | 2026-12 |
| NCT07944833Shengjing HospitalMechanical Characterization of Vestibular Schwannoma: Classification Based on Magnetic Resonance Elastography and Its Clinical Relevance Study | 2027-02-01 |
| NCT07479446Xuanwu Hospital, BeijingOliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery | 2027-08-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 10 studies in Neuroma, Acoustic with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This retrospective study aims at investigating the value of preoperative magnetic resonance elastography (MRE) in assessing the biomechanical characteristics of vestibular schwannomas and predicting surgical risk. Tumor stiffness and three-dimensional adhesion characteristics will be quantitatively analyzed and correlated with clinical parameters, including intraoperative tumor consistency and adhesion severity, operative time, blood loss, and postoperative neurological function. The study aims to validate the associations between MRE-derived imaging parameters, intraoperative findings, and clinical outcomes, thereby providing an imaging-based foundation for preoperative risk assessment and individualized surgical planning for vestibular schwannomas.
Vestibular schwannomas exhibit considerable variability in tumor stiffness and adhesion to surrounding tissues, which may influence surgical complexity, the extent of resection, and postoperative neurological recovery. Conventional magnetic resonance imaging (MRI) provides information on tumor morphology and its anatomical relationships with adjacent structures; however, it remains limited in quantitatively characterizing intratumoral stiffness and three-dimensionally assessing adhesion characteristics at the tumor interface. This study aims to systematically evaluate the ability of magnetic resonance elastography to quantitatively characterize the biomechanical properties of vestibular schwannomas and explore its clinical utility in preoperative surgical risk stratification.
All participants will undergo conventional preoperative MRI and MRE examinations. Relevant clinical data, including hearing status and facial nerve function, will also be collected. Post-processing of MRE images will be performed to extract quantitative parameters reflecting tumor stiffness and generate stiffness distribution maps across different tumor regions. In addition, three-dimensional sliding interface imaging-related techniques will be used to characterize adhesion features at the interface between the tumor and adjacent tissues, enabling a comprehensive assessment of spatial heterogeneity in tumor stiffness and the biomechanical properties of tissue interfaces.During surgery, intraoperative findings, including tumor consistency, adhesion severity, operative time, intraoperative blood loss, and extent of tumor resection, will be systematically documented. Postoperative facial nerve function, hearing outcomes, and relevant histopathological data will also be collected.
Statistical analyses will be selected according to the nature of the outcome variables and will include correlation analyses, regression analyses, and receiver operating characteristic (ROC) curve analyses to evaluate the diagnostic performance of MRE parameters and their associations with surgical outcomes. The potential predictive value of tumor stiffness and adhesion characteristics for clinical outcomes, particularly postoperative facial nerve function, will be further explored. This study aims to establish an integrated framework linking preoperative quantitative imaging measurements with intraoperative biomechanical findings and postoperative clinical outcomes, thereby providing an imaging-based foundation for preoperative risk assessment, and individualized clinical decision-making in patients with vestibular schwannomas.
This study will enroll adult patients with unilateral sporadic vestibular schwannoma who are scheduled to undergo microsurgical resection at Shengjing hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-All patients undergoing vestibular schwannoma resection surgery are eligible for inclusion in the study cohort.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will undergo preoperative magnetic resonance elastography . Quantitative tumor stiffness parameters will be derived through image post-processing, and a three-dimensional map of tumor adhesion characteristics will be generated. MRE-derived imaging parameters will be analyzed in relation to intraoperative findings, including tumor consistency, adhesion severity, operative time, blood loss, and extent of resection. Postoperative facial nerve function, hearing outcomes, and relevant histopathological data will also be collected to evaluate the potential predictive value of MRE parameters for surgical risk and clinical outcomes.
Association of Preoperative MRE-Derived Quantitative Parameters With Intraoperative Tumor Consistency and Adhesion Severity
Quantitative tumor stiffness parameters and three-dimensional adhesion characteristics derived from preoperative magnetic resonance elastography will be analyzed and compared with intraoperative assessments of tumor consistency and adhesion severity. The ability of MRE-derived parameters to characterize the biomechanical properties of vestibular schwannomas will be evaluated. Correlation analyses and, where appropriate, receiver operating characteristic (ROC) curve analyses will be performed to assess the associations and discriminative performance of imaging parameters in relation to intraoperative findings.
Time frame: From preoperative MRE examination to surgery; intraoperative assessments will be performed during tumor resection.
Plan to share: No
Started Aug 2026 (actual). Primary completion is estimated for Feb 2027, 5 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.